Scarica l'app Stockscreener
71.48
0.53%
-0.38
Pre-mercato:
71.50
0.02
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$71.86
Aprire:
$71.5
Volume 24 ore:
18.87M
Relative Volume:
2.25
Capitalizzazione di mercato:
$90.94B
Reddito:
$402.11B
Utile/perdita netta:
$1.73B
Rapporto P/E:
51.67
EPS:
1.3835
Flusso di cassa netto:
$7.81B
1 W Prestazione:
-6.11%
1M Prestazione:
-6.79%
6M Prestazione:
-4.59%
1 anno Prestazione:
+4.14%
Intervallo 1D:
$70.21
$71.73
Intervallo di 1 settimana:
$70.21
$77.08
Portata 52W:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
71.48 | 90.94B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
275.59 | 250.15B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
262.84 | 69.30B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
291.48 | 64.33B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
169.90 | 20.40B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS Health Corp. stock under valuation scrutiny after governance overhaul signals cash flow pressure - AD HOC NEWS
CVS (CVS) director John Gallina granted 582 shares as semi-annual retainer - Stock Titan
Best Healthcare Stocks to Buy After the Market Pullback - Yahoo Finance
Best Healthcare Stocks to Buy After the Market Pullback - The Motley Fool
John E. Gallina becomes CVS Health (CVS) reporting director on Form 3 - Stock Titan
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
CVS Health appoints John E. Gallina to board of directors and audit committee - Investing.com
CVS, Caremark Pocket Money Meant For Rebates, Suit Claims - Law360
CVS Health adds John E. Gallina to board, names him Audit Committee financial expert - TradingView
Former Elevance CFO John Gallina joins CVS Health (CVS) board and audit committee - Stock Titan
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Lawsuit: CVS Caremark inflated drug costs via ‘manipulation scheme’ - InsuranceNewsNet
CVS Declares Consistent Quarterly Dividend Amid Legal Settlement - GuruFocus
CVS Health sets May 4 payout for 66.5-cent quarterly dividend - Stock Titan
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
CVS Health may have violated antitrust laws, Republican lawmakers say - MSN
CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End - Finviz
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
CVS Pharmacy's New AI-Driven Health Screening Expands Access Nationwide Amid Rising Chronic Disease - AD HOC NEWS
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS Remains in Turnaround Mode, Shooting for Ambitious Targets Through 2028 - Morningstar
CVS Health Corporation $CVS Shares Purchased by National Bank of Canada FI - MarketBeat
Moore Capital Management LP Sells 50,000 Shares of CVS Health Corporation $CVS - MarketBeat
Elevation Point Wealth Partners LLC Increases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Best Health Insurance Stocks for 2026 and How to Invest - The Motley Fool
Iron Triangle Partners LP Has $60.15 Million Stake in CVS Health Corporation $CVS - MarketBeat
KKM Financial LLC Grows Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Stock Holdings Reduced by Holocene Advisors LP - MarketBeat
150,000 Shares in CVS Health Corporation $CVS Acquired by Capitolis Liquid Global Markets LLC - MarketBeat
Chevy Chase Trust Holdings LLC Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
California Public Employees Retirement System Has $175.91 Million Stake in CVS Health Corporation $CVS - MarketBeat
Bank of Nova Scotia Has $68.82 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp Stock (ISIN: US1266501006) Eyes Recovery Amid Analyst Upgrades and Solid FY26 Guidan - AD HOC NEWS
CVS Health Q4 Earnings Beat Expectations but Unchanged 2026 Guidance Tempers Optimism - AD HOC NEWS
Seniors Overpaid Medicare Premiums By $13.4B In 2025. That's About $212 For Every Enrollee, Joint Economic Committee EstimatesCVS Health (NYSE:CVS), UnitedHealth Group (NYSE:UNH) - Benzinga
CVS Health Corporation $CVS Shares Bought by Calydon Capital - MarketBeat
Braidwell LP Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
1,174,797 Shares in CVS Health Corporation $CVS Bought by 8 Knots Management LLC - MarketBeat
CVS SEC FilingsCvs Health Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Health100: CVS Health's AI-Powered Platform Reshaping Patient Engagement in 2026 - AD HOC NEWS
Volterra Technologies LP Acquires 18,009 Shares of CVS Health Corporation $CVS - MarketBeat
Ossiam Sells 114,404 Shares of CVS Health Corporation $CVS - MarketBeat
Quinn Opportunity Partners LLC Has $8.37 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Integral Health Asset Management LLC - MarketBeat
Dodge & Cox Cuts Stock Position in CVS Health Corporation $CVS - MarketBeat
Callodine Capital Management LP Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Tocqueville Asset Management L.P. Cuts Position in CVS Health Corporation $CVS - MarketBeat
Landscape Capital Management L.L.C. Raises Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health stock price target kept at $105 by TD Cowen on survey data - Investing.com
CVS Health Corp Stock (ISIN: US1266501006) Gains Momentum on Bernstein Upgrade to Outperform - AD HOC NEWS
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):